home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Collection of Education
/
collectionofeducationcarat1997.iso
/
HEALTH
/
MED9602.ZIP
/
M9620625.TXT
< prev
next >
Wrap
Text File
|
1996-02-26
|
2KB
|
37 lines
Document 0625
DOCN M9620625
TI [Peliosis hepatitis during intestinal lymphomatous polyposis treated
with chemotherapy and radiotherapy. Regression after antibiotic therapy]
DT 9602
AU Abdelli N; Bouhnik Y; Lavergne-Slove A; Messing B; Galian A; Rambaud JC;
Service d'Hepato-Gastroenterologie et d'Assistance Nutritive,; Hopital
Saint-Lazare, Paris.
SO Gastroenterol Clin Biol. 1995 May;19(5):537-41. Unique Identifier :
AIDSLINE MED/96008772
AB We report a case of regressive peliosis hepatis, which occurred in a 55
year-old woman with diffuse intestinal lymphomatous polyposis in
remission after treatment with chemotherapy and radiotherapy, and which
was cleared after one month treatment with erythromycin. The
Warthin-Sarry stain, performed to identify a specific agent such as
Rochalimaea quintana and henselae, was negative, and the polymerase
chain reaction technique could not be performed. Regressive cases of
peliosis hepatis are rare, and 4 out of 7 have been reported after
antibiotic treatment. Two of them were observed after an antibiotic
regimen with erythromycin in patients with HIV disease, and the bacilli
Rochalimaea quintana and henselae were identified in liver tissue with
Warthin-Starry stain and polymerase chain reaction technique. The
observation and the regressive cases recently reported elsewhere,
suggest that appropriate antibiotic treatment should be proposed when
peliosis hepatis occurs.
DE Antibiotics, Macrolide/THERAPEUTIC USE Antineoplastic Agents,
Combined/THERAPEUTIC USE Case Report Combined Modality Therapy
English Abstract Erythromycin/*THERAPEUTIC USE Female Human
Intestinal Neoplasms/*COMPLICATIONS/DRUG THERAPY/RADIOTHERAPY Lymphoma,
Small Cleaved-Cell, Diffuse/*COMPLICATIONS/DRUG THERAPY/ RADIOTHERAPY
Middle Age Peliosis Hepatis/DRUG THERAPY/*ETIOLOGY/PATHOLOGY Remission
Induction JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).